Advertisement
Advertisement
-
TOPIC

Made in China 2025

Made in China 2025
Launched by Premier Li Keqiang in 2015, the “Made in China 2025" strategy aims to guide the country’s industrial modernisation, including the substitution of foreign technology with innovation developed on the mainland.
The recent wave of investment in AI drug development aligns with Beijing’s drive for technological self-sufficiency. Photo: Shutterstock
Biomedicine: Industry Trends

Capital injection: China backs AI drug makers in self-reliance drive

A wave of government-linked investment is boosting Chinese AI drug makers, underscoring Beijing’s drive to build its own biotech ecosystem.

Biomedicine: Companies

Chinese healthcare firms expand overseas to support growing expat community

Biomedicine: Industry Trends

Fosun Pharma unit licenses lung cancer drug to Eisai in US$1.55 billion deal

IPO

Morgan Stanley sees another record year for Hong Kong IPOs as pipeline hits 450

Mainland China’s issuers will still dominate city’s IPO market, executive says, but US and Southeast Asian companies are also joining in.

Mainland China’s issuers will still dominate city’s IPO market, Morgan Stanley executive says. Photo: Reuters
Biomedicine: Geopolitics

Exclusive | China challenges US in AI drug race, but rivals still reliant on each other

While US biotech firms increase use of Chinese clinical data, Chinese firms need US counterparts for monetisation, investor and scientist says.

Biomedicine: Industry Trends

Novartis, SciNeuro deal offers hope for 55 million suffering from Alzheimer’s

SciNeuro’s anti-amyloid programme is one of the firm’s key strategic research and development priorities to target the brain disease.

videocam
Advertisement
Advertisement
Advertisement
Biomedicine: Industry Trends

China’s weight-loss drug war: prices slashed up to 80% as obesity crisis worsens

Foreign, local firms fight for market share as number of overweight or obese adults could top 630 million by 2050, from 400 million in 2021.

There were more than 400 million overweight or obese adults in China in 2021, according to a study. Photo: Getty Images
Biomedicine: Companies

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025

Chinese drug makers signed 157 out-licensing deals with global pharmaceutical firms last year versus 94 a year earlier.

Biomedicine: Industry Trends

Meow or never: China’s pudgy pets spark race for weight-loss drugs

Fosun and Huadong biotech labs eye feline obesity drugs as owners weigh cuteness against health risks.

China manufacturing

China’s next decade to cement status as hi-tech manufacturing power: reports

The coming 10 years will see significant advances in cutting-edge sectors, reinforcing industrial dominance, according to new reports.

videocam
7
Robots carry out welding operations at the FAW-Volkswagen production based in Jimo district, Qingdao, eastern China’s Shandong province, on February 19. Photo: AFP
Mainland China

Chinese firms flock to Dubai free zones to navigate trade barriers, expand reach

JD.com, CNBM, carmakers and hundreds of other Chinese companies use the hub to reach consumers across Asia, Africa and Europe.

The Jebel Ali Free Zone at the western end of Dubai. Photo: Handout
Biomedicine: Industry Trends

China’s rising biotech clout on show in flurry of billion-dollar licensing deals

A burst of overseas licensing pacts is spotlighting China’s biotech sector, as Jacobio, Coherent Biopharma and Harbour BioMed land deals.

China economy

Opinion | Arguing about China’s overcapacity overlooks its drive for clean energy

What is often described as overcapacity is the outcome of a development strategy that treats energy as the foundation of economic capability.

videocam
United States

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

US drugmakers are increasingly looking to Chinese biotechs as an answer to the revenue gaps left by the looming ‘patent cliff’. Illustration by Henry Wong
Biomedicine: Industry Trends

China’s pharmaceutical industry transforms into a global innovation powerhouse

The China Pharmaceutical Innovation and Invention Index, a new gauge, highlights top drug makers on the mainland for the first time.

China is gaining a solid reputation as a pharmaceutical innovation hub, according to global consultancy Idea Pharma. Photo: AP
Mainland China

Can rising lithium costs save China’s energy storage firms from a price war?

China’s battery makers raise prices amid lithium rebound and global AI energy demand.

Biomedicine: Policy

China’s new drug insurance: lifeline for patients or squeeze on big firms?

New insurance formulary trims costs of Alzheimer’s and cancer therapies and marks a small win for global novel drug makers.

Advertisement
Advertisement
Advertisement
Biomedicine: Companies

Chinese biotech Scizeng’s global licensing deal to yield up to US$1.44 billion

Yarrow Bioscience gets exclusive global rights for the GenSci098 therapy to treat thyroid eye disease and Graves’ disease.

A number of Chinese biotech firms have clinched licensing deals with multinational companies this year. Photo: Shutterstock
Robotics

China’s Unitree teases platform allowing users to control robots via smartphones

Hangzhou robotics unicorn’s platform is designed to bring embodied intelligence into everyday life.

Biomedicine: Companies

China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer

Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.

Mainland China

Exclusive | China’s oldest shipyard Jiangnan plans world’s first nuclear-powered vessel

Construction on 25,000-container ship could start in the next 10 years, but a lot remains to be done, a top executive says.

6
A model of a nuclear-powered container ship is displayed at the Marintec China expo in Shanghai last week. Photo: China News Service/VCG via Getty Images
Robotics

China’s Pudu Robotics rolls out overseas charm offensive with robot dog

Quadruped dubbed D5 from Pudu – founded by former HKUST engineering student Felix Zhang – draws crowds at Tokyo expo.

Pudu Robotics’ latest quadruped model, D5, debuted at IREX. Photo: Wency Chen
Zhongshan

End of an era: Japan’s Canon shuts China printer plant as local rivals rise

Closure marks a turning point, where Chinese brands have not only caught up with foreign rivals but have also begun to dominate home market.

Robotics

Tsinghua University sets up research institute in push for robotics talent

The Institute for Embodied Intelligence and Robotics will be led by Zhang Tao, director of the university’s automation department.

China shipbuilding

China’s CSSC unveils plans for cruise, deep-sea and nuclear-powered vessels

CSSC’s plan to develop specialised vessels is in line with Beijing’s ambition to transform the country into a shipbuilding powerhouse.

4
CSSC says its growing strength in building advanced vessels is reflected in the construction of Adora Flora City. Photo: Getty
Mainland China

Chinese EV makers tipped to storm global top 10 carmakers by 2030, McKinsey says

Chinese carmakers are expected to climb the global league tables over the next five years, as technology and scale disrupt the leaders.

China’s EV makers are expected to be among the top 10 in the world league table by 2030. Photo: Xinhua
China economy

Opinion | The rise of a Beijing-led ‘Global South Consensus’

As the Global South seeks a better development model and China looks for alternatives to mature markets, a match made out of mutual need is emerging.

videocam
US-China relations

China sees progress while US sees threat in industrial success

A US Congressional commission highlights advances made by China under an industrial programme, as well as laying out recommendations to curb national security risks.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement